The selective therapeutic apheresis procedures

J Clin Apher. 2013 Feb;28(1):20-9. doi: 10.1002/jca.21265.

Abstract

Selective apheresis procedures have been developed to target specific molecules, antibodies, or cellular elements in a variety of diseases. The advantage of the selective apheresis procedures over conventional therapeutic plasmapheresis is preservation of other essential plasma components such as albumin, immunoglobulins, and clotting factors. These procedures are more commonly employed in Europe and Japan, and few are available in the USA. Apheresis procedures discussed in this review include the various technologies available for low-density lipoprotein (LDL) apheresis, double filtration plasmapheresis (DFPP), cryofiltration, immunoadsorption procedures, adsorption resins that process plasma, extracorporeal photopheresis, and leukocyte apheresis.

Publication types

  • Review

MeSH terms

  • Autoantibodies / blood
  • Blood Cells
  • Blood Component Removal / instrumentation
  • Blood Component Removal / methods*
  • Cryoglobulins
  • Filtration / instrumentation
  • Filtration / methods
  • Humans
  • Immobilized Proteins
  • Immunoglobulins / blood
  • Immunosorbent Techniques / instrumentation
  • Lipids / blood
  • Lipoproteins / blood
  • Photopheresis / instrumentation
  • Photopheresis / methods
  • Resins, Synthetic
  • Staphylococcal Protein A
  • United States

Substances

  • Autoantibodies
  • Cryoglobulins
  • Immobilized Proteins
  • Immunoglobulins
  • Lipids
  • Lipoproteins
  • Resins, Synthetic
  • Staphylococcal Protein A